DocWire News Editors

DocwireNews

Primary aldosteronism (PA) is the most common form of secondary hypertension.&nbsp;Interesting enough, when compared with primary hypertension, PA causes more end-organ damage and is associated with excess cardiovascular morbidity, including heart failure, stroke, nonfatal myocardial infarction, and atrial fibrillation.&nbsp;Although screening opportunities are available, the screening rates for PA are low. In a study published by Circulation, researchers discuss&nbsp;a practical approach to PA screening&nbsp;and that any clinician&nbsp;that treats hypertension should routinely screen appropriate patients for PA.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<a href="https://twitter.com/hashtag/InDepth?src=hash&amp;ref_src=twsrc%5Etfw">#InDepth</a>: Primary aldosteronism: A Practical approach to diagnosis and management <a href="https://twitter.com/thebyrdlab?ref_src=twsrc%5Etfw">@thebyrdlab</a> <a href="https://t.co/vRiyZv1WtK">https://t.co/vRiyZv1WtK</a> <a href="https://t.co/poZywU3eKc">pic.twitter.com/poZywU3eKc</a>
&mdash; Circulation (@CircAHA) <a href="https://twitter.com/CircAHA/status/1031994432768356352?ref_src=twsrc%5Etfw">August 21, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>According to the study,&nbsp;primary aldosteronism is defined as &ldquo;inappropriately elevated aldosterone production in the setting of low plasma renin.&rdquo;&nbsp;Originally, PA was thought to be rare but is now known to be the most common cause of secondary hypertension.&nbsp;Early identification of PA&nbsp;is&nbsp;essential&nbsp;in order to&nbsp;appropriately&nbsp;and specifically&nbsp;treat it,&nbsp;but&nbsp;PA remains underrecognized by both internists and specialists.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Nice review by <a href="https://twitter.com/thebyrdlab?ref_src=twsrc%5Etfw">@thebyrdlab</a> &amp; colleagues re: primary aldosteronism <a href="https://t.co/35YoJ9P28c">https://t.co/35YoJ9P28c</a> <a href="https://twitter.com/CircAHA?ref_src=twsrc%5Etfw">@CircAHA</a> <a href="https://t.co/BSoXZ2aYXb">pic.twitter.com/BSoXZ2aYXb</a>
&mdash; Pradeep Natarajan (@pnatarajanmd) <a href="https://twitter.com/pnatarajanmd/status/1031686185528320000?ref_src=twsrc%5Etfw">August 20, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
When I became a high blood specialist &amp; then a cardiologist, little did I anticipate that I would need to learn about somatic mutations. I was sure that was for the oncologists! Au contraire!<a href="https://t.co/1eES2HTsuH">https://t.co/1eES2HTsuH</a>
&mdash; J. Brian Byrd Lab (@thebyrdlab) <a href="https://twitter.com/thebyrdlab/status/1032064764825006080?ref_src=twsrc%5Etfw">August 22, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>The study states that out of U.S. patients with primary aldosteronism, 1 in 550 is&nbsp;actually&nbsp;diagnosed&nbsp;and treated for the condition&nbsp;and shows the issue with underdiagnosis.&nbsp;However, a recent&nbsp;expansion of knowledge&nbsp;has&nbsp;addressed&nbsp;the prevalence, pathophysiology, and&nbsp;the&nbsp;clinical approach to PA. In turn, this&nbsp;has provided an evidence-based understanding of this common condition.&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Primary aldosteronism: Useful review with a nice simplified algorithm. <a href="https://t.co/l6ipTDWWJN">https://t.co/l6ipTDWWJN</a> <a href="https://t.co/u4GO8PujPN">pic.twitter.com/u4GO8PujPN</a>
&mdash; James Deardorff (@wjdeardorff) <a href="https://twitter.com/wjdeardorff/status/1032026648592478213?ref_src=twsrc%5Etfw">August 21, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Check out&nbsp;an article on&nbsp;the concerns of using of&nbsp;<a class="Hyperlink SCXW121682423" href="https://proddocwire.wpengine.com/docwire-pick/out-of-hospital-cardiac-arrest-2/" target="_blank" rel="noopener noreferrer">epinephrine as a treatment for out-of-hospital cardiac arrest</a>.&nbsp;SOURCE:&nbsp;<a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.033597">Circulation&nbsp;</a>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

A Practical Approach to the Diagnosis of Primary Aldosteronism

Cardiology

Primary aldosteronism (PA) is the most common form of secondary hypertension. Interesting enough, when compared with primary hypertension, PA causes more end-organ damage and ...